In our dataset of upregulated transcripts, we also find complement proteins (i.e., C3 and C1s2) which are known to contribute to the synaptopathy present in Alzheimer’s disease (Hong et al., 2016). This evidence concerns the gene C3 and early-onset autosomal dominant Alzheimer disease.